844
Views
75
CrossRef citations to date
0
Altmetric
Research Article

Radiation metabolomics and its potential in biodosimetry

, , , , &
Pages 802-823 | Received 13 Sep 2010, Accepted 17 Jan 2011, Published online: 22 Jun 2011

References

  • Abbatiello SE, Mani DR, Keshishian H, Carr SA. 2010. Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. Clin Chem 56:291–305.
  • Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, et al. 2009. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nature Biotechnology 27:633–641.
  • Amundson SA, Do KT, Fornace AJ, Jr. 1999. Induction of Stress Genes by Low Doses of Gamma Rays. Radiation Research 152:225–231.
  • Amundson SA, Do KT, Vinikoor L, Koch-Paiz CA, Bittner ML, Trent JM, Meltzer P, Fornace AJJ. 2005. Stress-specific signatures: expression profiling of p53 wild-type and -null human cells. Oncogene 24:4572–4579.
  • Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, Ahn J, Reimers M, Chen Y, Scudiero DA, Weinstein JN, et al. 2008. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Research 68:415–424.
  • Amundson SA, Grace MB, McLeland CB, Epperly MW, Yeager A, Zhan Q, Greenberger JS, Fornace AJ, Jr. 2004. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Research 64:6368–6371.
  • Amundson SA, Lee A, Koch-Paiz C, Bittner ML, Meltzer P, Trent JM, Fornace AJ, Jr. 2003. Differential responses of stress genes to low dose-rate gamma-irradiation. Mol Cancer Res 1:445–452.
  • Bao Y, Zhao T, Wang X, Qiu Y, Su M, Jia W, Jia W. 2009. Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. J Proteome Res 8:1623–1630.
  • Brengues M, Paap B, Bittner M, Amundson S, Seligmann B, Korn R, Lenigk R, Zenhausern F. 2010. Biodosimetry on small blood volume using gene expression assay. Health Physics 98:179–185.
  • Bulavin DV, Fornace AJ, Jr. 2004. p38 MAP kinase's emerging role as a tumor suppressor. Advances in Cancer Research 92:95–118.
  • Burns TF, El-Deiry WS. 2003. Microarray analysis of p53 target gene expression patterns in the spleen and thymus in response to ionizing radiation. Cancer Biol Ther 2:431–443.
  • Bylesjo M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J. 2006. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemometrics 20:341–351.
  • Carr SA. 2009. Protein Quantification through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory? Molecular & Cellular Proteomics. S16–S16.
  • Covey TR, Thomson BA, Schneider BB. 2009. Atmospheric pressure ion sources. Mass Spectrom Rev 28:870–897.
  • Coy SL, Krylov EV, Schneider BB, Covey TR, Brenner DJ, Tyburski JB, Patterson AD, Krausz KW, Fornace AJ, Nazarov EG. 2010. Detection of Radiation-Exposure Biomarkers by Differential Mobility Prefiltered Mass Spectrometry (DMS-MS). Int J Mass Spectrom 291:108–117.
  • Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, Westler WM, Eghbalnia HR, Sussman MR, Markley JL. 2008. Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol. 162–164.
  • Dettmer K, Aronov PA, Hammock BD. 2007. Mass spectrometry-based metabolomics. Mass Spectrom Rev 26:51–78.
  • Dettmer K, Hammock BD. 2004. Metabolomics–a new exciting field within the “omics” sciences. Environ Health Perspect 112:A396–7.
  • DiCarlo AL, Ramakrishnan N, Hatchett RJ. 2010. Radiation combined injury: overview of NIAID research. Health Phys 98:863–867.
  • Dwivedi P, Wu P, Klopsch SJ, Puzon GJ, Xun L, Hill HH. 2008. Metabolic profiling by ion mobility mass spectrometry (IMMS). Metabolomics 4:63–80.
  • Eichler GS, Huang S, Ingber DE. 2003. Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics 19:2321–2322.
  • Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. 2009. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical Chemistry 81:6656–6667.
  • Fedrigo M, Hoeschen C, Oeh U. 2010. Multidimensional statistical analysis of PTR-MS breath samples: A test study on irradiation detection. International J Mass Spectrometry 295:13–20.
  • Feng Z, Levine AJ. 2010. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol 20:427–434.
  • Fiehn O. 2002. Metabolomics–the link between genotypes and phenotypes. Plant Mol Biol 48:155–171.
  • Garty G, Chen YH, Salerno A, Turner H, Zhang J, Lyulko O, Bertucci A, Xu YP, Wang HL, Simaan N, et al. 2010. The Rabit: A Rapid Automated Biodosimetry Tool for Radiological Triage. Health Physics 98:209–217.
  • Goodsaid FM, Amur S, Aubrecht J, Burczynski ME, Carl K, Catalano J, Charlab R, Close S, Cornu-Artis C, Essioux L, et al. 2010. Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact. Nat Rev Drug Discov 9:435–445.
  • Halket JM, Waterman D, Przyborowska AM, Patel RK, Fraser PD, Bramley PM. 2005. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J Exp Bot 56:219–243.
  • Hall EJ, Giaccia AJ. 2006. Radiobiology for the Radiologist.
  • Hassa PO, Hottiger MO. 2008. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 13:3046–3082.
  • Hei TK, Zhou H, Ivanov VN, Hong M, Lieberman HB, Brenner DJ, Amundson SA, Geard CR. 2008. Mechanism of radiation-induced bystander effects: a unifying model. Journal of Pharmacy and Pharmacology 60:943–950.
  • Hofseth LJ, Hussain SP, Harris CC. 2004. p53: 25 years after its discovery. Trends Pharmacol Sci 25:177–181.
  • Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, et al. 2010. A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response. Cell 142:409–419.
  • Issaq HJ, Abbott E, Veenstra TD. 2008. Utility of separation science in metabolomic studies. Journal of Separation Science 31:1936–1947.
  • Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, Getz G, Domany E, Givol D. 2001. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20:2225–2234.
  • Kastan MB, Bartek J. 2004. Cell-cycle checkpoints and cancer. Nature 432:316–323.
  • Katajamaa M, Oresic M. 2007. Data processing for mass spectrometry-based metabolomics. Journal of Chromatography A.318–328.
  • Kertesz V, Van Berkel GJ. 2010. Liquid microjunction surface sampling coupled with high-pressure liquid chromatography-electrospray ionization-mass spectrometry for analysis of drugs and metabolites in whole-body thin tissue sections. Analytical Chemistry 82:5917–5921.
  • Khanna V, Ranganathan S. 2009. Physiochemical property space distribution among human metabolites, drugs and toxins. BMC Bioinformatics 10 Suppl 15:S10.
  • Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, Thompson IM, Weiss RH. 2009. Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8:558–570.
  • Kitagawa R, Kastan MB. 2005. The ATM-dependent DNA damage signaling pathway. Cold Spring Harbor Symposia on Quantitative Biology 70:99–109.
  • Krylov EV, Coy SL, Vandermey J, Schneider BB, Covey TRNazarov EG. 2010. Selection and generation of waveforms for differential mobility spectrometry. Rev Sci Instrum 81:024101.
  • Krylov EV , Nazarov EG. 2009. Electric field dependence of the ion mobility. International J of Mass Spectrometry 285:149–156.
  • Ku WW, Aubrecht J, Mauthe RJ, Schiestl RH, Fornace AJ, Jr. 2007. Why Not Start With a Single Test: A Transformational Alternative to Genotoxicity Hazard and Risk Assessment. Toxicol Sci 99:20–25.
  • Laiakis EC, Morris GA, Fornace AJ, Jr, Howie SR. 2010. Metabolomic analysis in severe childhood pneumonia in the gambia, west Africa: findings from a pilot study. PLoS ONE 5:e12655.
  • Lanz C, Patterson AD, Slavik J, Krausz KW, Ledermann M, Gonzalez FJ, Idle JR. 2009. Radiation metabolomics. 3. Biomarker discovery in the urine of gamma-irradiated rats using a simplified metabolomics protocol of gas chromatography-mass spectrometry combined with random forests machine learning algorithm. Radiation Research 172:198–212.
  • Levin DS, Vouros P, Miller RA, Nazarov EG, Morris JC. 2006. Characterization of gas-phase molecular interactions on differential mobility ion behavior utilizing an electrospray ionization-differential mobility-mass spectrometer system. Analytical Chemistry 78:96–106.
  • Li HH, Aubrecht J, Fornace AJ, Jr. 2007. Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals. Mutat Res 623:98–108.
  • Lin Y, Schiavo S, Orjala J, Vouros P, Kautz R. 2008. Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. Analytical Chemistry 80:8045–8054.
  • Lorimore SA, Coates PJ, Wright EG. 2003. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 22:7058–7069.
  • Lowe JM, Cha H, Yang Q, Fornace AJ, Jr. 2010. Nuclear factor-kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic Wip1 phosphatase. Journal of Biological Chemistry 285:5249–5257.
  • Luo Z, Zang M , Guo W. 2010. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 6:457–470.
  • Lutgens LC, Deutz NE, Gueulette J, Cleutjens JP, Berger MP, Wouters BG, von Meyenfeldt MF, Lambin P. 2003. Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. International Journal of Radiation Oncology, Biology, Physics 57:1067–1074.
  • Manard MJ, Trainham R, Weeks S, Coy SL, Krylov EV, Nazarov EG. 2010. Differential mobility spectrometry/mass spectrometry: The design of a new mass spectrometer for real-time chemical analysis in the field. International J Mass Spectrometry 295:138–144.
  • McLean JA. 2009. The mass-mobility correlation redux: the conformational landscape of anhydrous biomolecules. J Am Soc Mass Spectrom 20:1775–1781.
  • Meek DW, Anderson CW. 2009. Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol 1:a000950.
  • Pandey BN, Kumar A, Tiwari P, Mishra KP. 2010. Radiobiological basis in management of accidental radiation exposure. International Journal of Radiation Biology 86:613–635.
  • Parizek J, Arient M, Dienstbier Z, Skoda J. 1958. Deoxycytidine in urine as an indicator of changes after irradiation. Nature 182:721–722.
  • Patterson AD, Gonzalez FJ, Idle JR. 2010a. Xenobiotic Metabolism: A View through the Metabolometer. Chemical Research in Toxicology 23:851–860.
  • Patterson AD, Idle JR, 2009, A metabolomic perspective of small molecule toxicity. General and Applied Toxicology,edited by TCMB Ballantyne T Syversen Chicheste, UKJohn Wiley & Sonspp. 18–44.
  • Patterson AD, Lanz C, Gonzalez FJ, Idle JR. 2010b. The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev 29:503–521.
  • Patterson AD, Li H, Eichler GS, Krausz KW, Weinstein JN, Fornace AJ, Jr, Gonzalez FJ, Idle JR. 2008. UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Analytical Chemistry 80:665–674.
  • Paul S, Amundson SA. 2008. Development of gene expression signatures for practical radiation biodosimetry. International Journal of Radiation Oncology, Biology, Physics 71:1236–1244.
  • Ramautar R, van der Plas AA, Nevedomskaya E, Derks RJ, Somsen GW, de Jong GJ, van Hilten JJ, Deelder AM, Mayboroda OA. 2009. Explorative analysis of urine by capillary electrophoresis-mass spectrometry in chronic patients with complex regional pain syndrome. J Proteome Res 8:5559–5567.
  • Rohwer RG. 1984. Scrapie infectious agent is virus-like in size and susceptibility to inactivation. Nature 308:658–662.
  • Rosette C, Karin M. 1996. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274:1194–1197.
  • Salminen A, Kaarniranta K. 2010. Glycolysis links p53 function with NF-kappaB signaling: impact on cancer and aging process. Journal of Cellular Physiology 224:1–6.
  • Sanli T, Rashid A, Liu C, Harding S, Bristow RG, Cutz JC, Singh G, Wright J, Tsakiridis T. 2010. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. International Journal of Radiation Oncology, Biology, Physics 78:221–229.
  • Santini MT, Romano R, Rainaldi G, Ferrante A, Motta A , Indovina PL. 2006. Increases in 1H-NMR mobile lipids are not always associated with overt apoptosis: evidence from MG-63 human osteosarcoma three-dimensional spheroids exposed to a low dose (2 Gy) of ionizing radiation. Radiation Research 165:131–141.
  • Schauer N, Steinhauser D, Strelkov S, Schomburg D, Allison G, Moritz T, Lundgren K, Roessner-Tunali U, Forbes MG, Willmitzer L, et al. 2005. GC-MS libraries for the rapid identification of metabolites in complex biological samples. FEBS Letters 579:1332–1337.
  • Schieven GL. 2005. The biology of p38 kinase: a central role in inflammation. Curr Top Med Chem 5:921–928.
  • Schneider BB, Covey TR, Coy SL, Krylov EV, Nazarov EG. 2010a. Control of chemical effects in the separation process of a differential mobility mass spectrometer system. Eur J Mass Spectrom (Chichester, Eng) 16:57–71.
  • Schneider BB, Covey TR, Coy SL, Krylov EV, Nazarov EG. 2010b. Planar differential mobility spectrometer as a pre-filter for atmospheric pressure ionization mass spectrometry. Int J Mass Spectrom 298:45–54.
  • Schneider BB, Covey TR, Coy SL, Krylov EV, Nazarov EG. 2010c. Chemical effects in the separation process of a differential mobility/mass spectrometer system. Analytical Chemistry 82:1867–1880.
  • Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, Bernal-Mizrachi C, Muslin AJ, Kastan MB, Semenkovich CF. 2006. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4:377–389.
  • Schneidkraut MJ, Kot PA, Ramwell PW, Rose JC. 1984. Thromboxane and prostacyclin synthesis following whole body irradiation in rats. J Appl Physiol 57:833–838.
  • Schuler M, Green DR. 2005. Transcription, apoptosis and p53: catch-22. Trends in Genetics 21:182–187.
  • Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G. 2005. METLIN: a metabolite mass spectral database. Ther Drug Monit 27:747–751.
  • Smith ML, Fornace AJ, Jr. 1996. The two faces of tumor suppressor p53. American Journal of Pathology 148:1019–1022.
  • Spratlin JL, Serkova NJ, Eckhardt SG. 2009. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15:431–440.
  • Stancevic B, Kolesnick R. 2010. Ceramide-rich platforms in transmembrane signaling. FEBS Letters 584:1728–1740.
  • Tadjimukhamedov FK, Jackson AU, Nazarov EG, Ouyang Z, Cooks RG. 2010. Evaluation of a differential mobility spectrometer/miniature mass spectrometer system. J Am Soc Mass Spectrom 21:1477–1481.
  • Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJJ, Gonzalez FJ, Idle JR. 2008. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiation Research 170:1–14.
  • Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJ, Jr, Gonzalez FJ, Idle JR. 2009. Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiation Research 172:42–57.
  • Valerie K, Yacoub A, Hagan MP, Curiel DT, Fisher PB, Grant S, Dent P. 2007. Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther 6:789–801.
  • Van Berkel GJ, Kertesz V. 2009. Application of a Liquid Extraction Based Sealing Surface Sampling Probe for Mass Spectrometric Analysis of Dried Blood Spots and Mouse Whole-Body Thin Tissue Sections. Analytical Chemistry 81:9146–9152.
  • van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ. 2006. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7:142.
  • Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033.
  • Varghese RS, Cheema A, Cheema P, Bourbeau M, Tuli L, Zhou B, Jung M, Dritschilo A, Ressom HW. 2010. Analysis of LC-MS data for characterizing the metabolic changes in response to radiation. J Proteome Res 9:2786–2793.
  • Vousden KH, Ryan KM. 2009. p53 and metabolism. Nat Rev Cancer 9:691–700.
  • Want EJ, Cravatt BF, Siuzdak G. 2005. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 6:1941–1951.
  • Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, et al. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207–219.
  • Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, et al. 2009. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Research 37:D603–10.
  • Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, et al. 2007. HMDB: the Human Metabolome Database. Nucleic Acids Research 35:D521–6.
  • Wolfram RM, Palumbo B, Chehne F, Palumbo R, Budinsky AC, Sinzinger H. 2004. (Iso) Prostaglandins in saliva indicate oxidation injury after radioiodine therapy. Rev Esp Med Nucl 23:183–188.
  • Yamaoka K, Obata T, Iriyama K, Iwasaki T , Hoshi Y. 1998. Simultaneous quantitative analysis of prostaglandins and thromboxane after low-dose X irradiation. Radiation Research 149:103–106.
  • Yin P, Zhao X, Li Q, Wang J, Li J, Xu G. 2006. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res 5:2135–2143.
  • Zhang XD, Qin ZH, Wang J. 2010. The role of p53 in cell metabolism. Acta Pharmacol Sin 31:1208–1212.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.